RI
OXFD

RTW Investments’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

RTW Investments’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-375,792
Closed -$5.25M – 45
2017
Q4 		$5.25M Sell
375,792
-656,578
-64% -$9.62M 0.88% 26
2017
Q3 		$17.3M Buy
1,032,370
+185,453
+22% +$3.02M 3.02% 12
2017
Q2 		$14.2M Buy
846,917
+234,014
+38% +$3.5M 3% 11
2017
Q1 		$9.49M Buy
612,903
+69,616
+13% +$994K 2.5% 12
2016
Q4 		$8.12M Buy
543,287
+307,387
+130% +$4.31M 3.06% 10
2016
Q3 		$2.96M Buy
+235,900
New +$2.37M 0.9% 24

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RTW Investments's OXFD Position: Q1 2018 in Review

RTW Investments sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2018, closing a stake of 375,792 shares — an estimated $5.25M sold.

RTW Investments first reported a position in OXFD in Q3 2016 and held it in 6 quarters. The position peaked at $17.3M in Q3 2017. 74 funds tracked by Wall St. Rank hold OXFD as of Q1 2018.

  • RTW Investments reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2018 after selling out during the quarter.
  • RTW Investments sold 375,792 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2018, an estimated $5.25M.
  • RTW Investments first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2016 and held it in 6 quarters.
  • RTW Investments's Oxford Immunotec Global PLC Ordinary Shares position peaked at $17.3M in Q3 2017.
  • 74 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2018.

Based on RTW Investments's 13F filing for Q1 2018, filed 14 May 2018.